Trevi Therapeutics, Inc. (TRVI)

Trevi Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 9, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Cap	1,500	386	92	116	22	45
Market Cap Growth	249.75%	321.47%	-20.91%	418.86%	-50.32%	-32.89%
Enterprise Value	1,328	278.77	9.56	-2.67	-5.86	13.98
Last Close Price	11.70	4.12	1.34	1.93	0.78	2.42
PE Ratio	-	-8.77	-4.62	-4.29	-0.52	-1.34
PB Ratio	8.99	3.87	1.11	1.08	1.31	1.65
P/TBV Ratio	7.69	4.22	1.61	1.16	1.05	1.60
P/FCF Ratio	-	-10.07	-2.87	-4.08	-0.77	-1.55
P/OCF Ratio	-	-10.08	-2.89	-4.11	-0.77	-1.55
EV/EBITDA Ratio	-	-5.43	-0.28	0.09	0.18	-0.43
EV/EBIT Ratio	-	-5.41	-0.28	0.09	0.18	-0.43
EV/FCF Ratio	-	-7.28	-0.30	0.09	0.20	-0.48
Debt / Equity Ratio	0.00	0.01	0.01	0.02	0.51	0.52
Debt / EBITDA Ratio	-0.02	-0.02	-0.04	-0.31	-0.45	-0.44
Debt / FCF Ratio	-0.02	-0.03	-0.04	-0.32	-0.50	-0.49
Net Debt / Equity Ratio	-1.02	-1.07	-0.99	-1.04	-1.30	-1.13
Net Debt / EBITDA Ratio	3.79	2.08	2.42	3.73	0.69	0.95
Net Debt / FCF Ratio	4.41	2.78	2.56	3.93	0.77	1.06
Quick Ratio	21.56	10.24	14.25	8.99	2.89	8.10
Current Ratio	21.93	10.41	15.03	9.15	2.98	8.33
Return on Equity (ROE)	-31.69%	-52.59%	-30.59%	-46.82%	-153.03%	-80.07%
Return on Assets (ROA)	-33.08%	-51.41%	-31.90%	-36.99%	-75.83%	-60.62%
Return on Invested Capital (ROIC)	911.32%	1707.29%	2292.67%	672.60%	779.82%	1134.56%
Return on Capital Employed (ROCE)	-35.33%	-56.01%	-35.12%	-44.19%	-96.47%	-67.42%
Earnings Yield	-3.01%	-11.41%	-21.64%	-23.32%	-190.49%	-74.79%
FCF Yield	-2.89%	-9.93%	-34.81%	-24.49%	-129.82%	-64.68%
Buyback Yield / Dilution	-14.69%	-15.98%	-2.02%	-101.47%	-95.19%	-7.09%

Updated Nov 13, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q